Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients

@article{Verschueren2007DevelopmentOS,
  title={Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients},
  author={Kilian Verschueren and Els Van Essche and Patrick C P M Verschueren and Veerle Taelman and Ren{\'e} Westhovens},
  journal={Clinical Rheumatology},
  year={2007},
  volume={26},
  pages={1969-1971}
}
We report two rheumatoid arthritis patients developing sarcoidosis possibly induced by etanercept. Both women, aged 46 and 53, had erosive, rheumatoid-factor-positive rheumatoid arthritis (RA) for 7 and 6 years, respectively. The eldest had received infliximab for over a year with good response, which was stopped because of a perfusion reaction. She developed a cough and dyspnea after 6 months of etanercept treatment. The other developed erythema nodosum and a plaque lesion on the right arm… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 38 extracted citations

Update on sarcoidosis.

Current opinion in ophthalmology • 2015
View 2 Excerpts

Medical therapy of sarcoidosis.

Seminars in respiratory and critical care medicine • 2014

References

Publications referenced by this paper.
Showing 1-10 of 11 references

Differentiating the efficacy of the tumor necrosis factor inhibitors.

Seminars in arthritis and rheumatism • 2005
View 1 Excerpt

The utility of tumour necrosis factor blockade in orphan diseases.

Annals of the rheumatic diseases • 2004
View 1 Excerpt

Similar Papers

Loading similar papers…